Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Immunology Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cell Therapy
1.2.3 Small Molecule Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next-Generation Immunology Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Immunology Drugs Market Perspective (2018-2033)
2.2 Next-Generation Immunology Drugs Growth Trends by Region
2.2.1 Global Next-Generation Immunology Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next-Generation Immunology Drugs Historic Market Size by Region (2018-2023)
2.2.3 Next-Generation Immunology Drugs Forecasted Market Size by Region (2024-2033)
2.3 Next-Generation Immunology Drugs Market Dynamics
2.3.1 Next-Generation Immunology Drugs Industry Trends
2.3.2 Next-Generation Immunology Drugs Market Drivers
2.3.3 Next-Generation Immunology Drugs Market Challenges
2.3.4 Next-Generation Immunology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Immunology Drugs Players by Revenue
3.1.1 Global Top Next-Generation Immunology Drugs Players by Revenue (2018-2023)
3.1.2 Global Next-Generation Immunology Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Immunology Drugs Revenue
3.4 Global Next-Generation Immunology Drugs Market Concentration Ratio
3.4.1 Global Next-Generation Immunology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Immunology Drugs Revenue in 2022
3.5 Next-Generation Immunology Drugs Key Players Head office and Area Served
3.6 Key Players Next-Generation Immunology Drugs Product Solution and Service
3.7 Date of Enter into Next-Generation Immunology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Immunology Drugs Breakdown Data by Type
4.1 Global Next-Generation Immunology Drugs Historic Market Size by Type (2018-2023)
4.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2024-2033)
5 Next-Generation Immunology Drugs Breakdown Data by Application
5.1 Global Next-Generation Immunology Drugs Historic Market Size by Application (2018-2023)
5.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next-Generation Immunology Drugs Market Size (2018-2033)
6.2 North America Next-Generation Immunology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Next-Generation Immunology Drugs Market Size by Country (2018-2023)
6.4 North America Next-Generation Immunology Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Immunology Drugs Market Size (2018-2033)
7.2 Europe Next-Generation Immunology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Next-Generation Immunology Drugs Market Size by Country (2018-2023)
7.4 Europe Next-Generation Immunology Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Immunology Drugs Market Size (2018-2033)
8.2 Asia-Pacific Next-Generation Immunology Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Immunology Drugs Market Size (2018-2033)
9.2 Latin America Next-Generation Immunology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Next-Generation Immunology Drugs Market Size by Country (2018-2023)
9.4 Latin America Next-Generation Immunology Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Immunology Drugs Market Size (2018-2033)
10.2 Middle East & Africa Next-Generation Immunology Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Detail
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Next-Generation Immunology Drugs Introduction
11.1.4 Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.1.5 Pfizer Inc Recent Development
11.2 Abbvie Inc.
11.2.1 Abbvie Inc. Company Detail
11.2.2 Abbvie Inc. Business Overview
11.2.3 Abbvie Inc. Next-Generation Immunology Drugs Introduction
11.2.4 Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.2.5 Abbvie Inc. Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Detail
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Next-Generation Immunology Drugs Introduction
11.3.4 Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.3.5 Johnson and Johnson Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Detail
11.5.2 Amgen Inc. Business Overview
11.5.3 Amgen Inc. Next-Generation Immunology Drugs Introduction
11.5.4 Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.5.5 Amgen Inc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Next-Generation Immunology Drugs Introduction
11.6.4 Novartis AG Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.6.5 Novartis AG Recent Development
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Company Detail
11.7.2 Astellas Pharma Inc. Business Overview
11.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Introduction
11.7.4 Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.7.5 Astellas Pharma Inc. Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Detail
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Company Detail
11.9.2 Merck & Co., Inc. Business Overview
11.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Introduction
11.9.4 Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.9.5 Merck & Co., Inc. Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Detail
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Introduction
11.10.4 Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2018-2023)
11.10.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next-Generation Immunology Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Small Molecule Drug
Table 4. Key Players of Others
Table 5. Global Next-Generation Immunology Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Next-Generation Immunology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Next-Generation Immunology Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Next-Generation Immunology Drugs Market Share by Region (2018-2023)
Table 9. Global Next-Generation Immunology Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Next-Generation Immunology Drugs Market Share by Region (2024-2033)
Table 11. Next-Generation Immunology Drugs Market Trends
Table 12. Next-Generation Immunology Drugs Market Drivers
Table 13. Next-Generation Immunology Drugs Market Challenges
Table 14. Next-Generation Immunology Drugs Market Restraints
Table 15. Global Next-Generation Immunology Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Next-Generation Immunology Drugs Market Share by Players (2018-2023)
Table 17. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2022)
Table 18. Ranking of Global Top Next-Generation Immunology Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Next-Generation Immunology Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next-Generation Immunology Drugs Product Solution and Service
Table 22. Date of Enter into Next-Generation Immunology Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next-Generation Immunology Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2024-2033)
Table 28. Global Next-Generation Immunology Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2024-2033)
Table 32. North America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Next-Generation Immunology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Next-Generation Immunology Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Next-Generation Immunology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Next-Generation Immunology Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Next-Generation Immunology Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Next-Generation Immunology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Next-Generation Immunology Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Inc Company Detail
Table 48. Pfizer Inc Business Overview
Table 49. Pfizer Inc Next-Generation Immunology Drugs Product
Table 50. Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 51. Pfizer Inc Recent Development
Table 52. Abbvie Inc. Company Detail
Table 53. Abbvie Inc. Business Overview
Table 54. Abbvie Inc. Next-Generation Immunology Drugs Product
Table 55. Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 56. Abbvie Inc. Recent Development
Table 57. Johnson and Johnson Company Detail
Table 58. Johnson and Johnson Business Overview
Table 59. Johnson and Johnson Next-Generation Immunology Drugs Product
Table 60. Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 61. Johnson and Johnson Recent Development
Table 62. F. Hoffmann-La Roche Ltd. Company Detail
Table 63. F. Hoffmann-La Roche Ltd. Business Overview
Table 64. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product
Table 65. F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd. Recent Development
Table 67. Amgen Inc. Company Detail
Table 68. Amgen Inc. Business Overview
Table 69. Amgen Inc. Next-Generation Immunology Drugs Product
Table 70. Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 71. Amgen Inc. Recent Development
Table 72. Novartis AG Company Detail
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Next-Generation Immunology Drugs Product
Table 75. Novartis AG Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. Astellas Pharma Inc. Company Detail
Table 78. Astellas Pharma Inc. Business Overview
Table 79. Astellas Pharma Inc. Next-Generation Immunology Drugs Product
Table 80. Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 81. Astellas Pharma Inc. Recent Development
Table 82. Bristol-Myers Squibb Company Company Detail
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product
Table 85. Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Merck & Co., Inc. Company Detail
Table 88. Merck & Co., Inc. Business Overview
Table 89. Merck & Co., Inc. Next-Generation Immunology Drugs Product
Table 90. Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 91. Merck & Co., Inc. Recent Development
Table 92. Eli Lilly and Company Company Detail
Table 93. Eli Lilly and Company Business Overview
Table 94. Eli Lilly and Company Next-Generation Immunology Drugs Product
Table 95. Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2018-2023) & (US$ Million)
Table 96. Eli Lilly and Company Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Immunology Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Next-Generation Immunology Drugs Market Share by Type: 2022 VS 2033
Figure 3. Cell Therapy Features
Figure 4. Small Molecule Drug Features
Figure 5. Others Features
Figure 6. Global Next-Generation Immunology Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Next-Generation Immunology Drugs Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Next-Generation Immunology Drugs Report Years Considered
Figure 12. Global Next-Generation Immunology Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Next-Generation Immunology Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Next-Generation Immunology Drugs Market Share by Region: 2022 VS 2033
Figure 15. Global Next-Generation Immunology Drugs Market Share by Players in 2022
Figure 16. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Next-Generation Immunology Drugs Revenue in 2022
Figure 18. North America Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Next-Generation Immunology Drugs Market Share by Country (2018-2033)
Figure 20. United States Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Next-Generation Immunology Drugs Market Share by Country (2018-2033)
Figure 24. Germany Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Next-Generation Immunology Drugs Market Share by Region (2018-2033)
Figure 32. China Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Next-Generation Immunology Drugs Market Share by Country (2018-2033)
Figure 40. Mexico Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Next-Generation Immunology Drugs Market Share by Country (2018-2033)
Figure 44. Turkey Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Next-Generation Immunology Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Inc Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 47. Abbvie Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 48. Johnson and Johnson Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 49. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 50. Amgen Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 51. Novartis AG Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 52. Astellas Pharma Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 54. Merck & Co., Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed